Slide 1 Slide 2 Slide 3 Slide 4
Our Product
Pellets & Granules
Finished Formulations

PROCESS PATENTS

Granted :
1. Preparation of Linezolid & its novel intermediate : US 9,376,407 B2; granted on 28-06-2016.
2. Preparation of Linezolid & its novel intermediate : EP 2595968 B1; granted on 09.09.2015
Filed :
1. Linezolid Form-II: European Patent Application : No. 12716665
2. Anhydrous Linezolid Crystalline Form-II   US Patent Application No. : 13/820565 WO 2012114354
3. Saxagliptin Adamantylglycine intermediate   Application No. : 4256/CHE/2007
4. Lurasidone Dicarboxylic Intermediate   Application No. : PCT/IN2013/000149
5. Montelukast Pharma   Application No. : 811/CHE/2013
6. Sitagliptin Phosphate Monhydrate   Application No. : PCT/IB/2015/051312
7. A Novel process for the preparation of Crystalline Linezolid Form -III   PCT/IN2016/050454
8. Stable Amorphous Form of Dipeptidyl Peptidase4(dpp4) enzyme Inhibitor : TEMP/E1/4173/2017CHE
Filed :
* New Chemical Entity (LDD012013) : IN5063/CHE/2013A PCT/IN2014/000497
* Novel Oxazolidinone Antibacterial Compound : IN2254/CHE/2014